Indication
Cirrhotic Cardiomyopathy
2 clinical trials
4 products
Clinical trial
Efficacy of Carvedilol + Ivabradine vs Carvedilol Alone for Left Ventricular Diastolic Dysfunction in Chronic Liver Disease Patients and Its' Impact on Morbidity and Mortality; a Prospective Randomized Controlled Trial.Status: Recruiting, Estimated PCD: 2024-10-01
Product
Betablocker + IvabradineProduct
BetablockerClinical trial
Carvedilol + Simvastatin vs. Carvedilol Alone for Chronic Liver Disease and Cirrhotic Cardiomyopathy and Its Impact on Hepatic Decompensation and Survival; a Double-blind Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Product
SimvastatinProduct
Carvedilol